EE200100572A - 1-(p-tienüülbensüül)imidasool, seda sisaldav farmatseutiline preparaat ja nende raviotstarbeline kasutamine - Google Patents

1-(p-tienüülbensüül)imidasool, seda sisaldav farmatseutiline preparaat ja nende raviotstarbeline kasutamine

Info

Publication number
EE200100572A
EE200100572A EEP200100572A EEP200100572A EE200100572A EE 200100572 A EE200100572 A EE 200100572A EE P200100572 A EEP200100572 A EE P200100572A EE P200100572 A EEP200100572 A EE P200100572A EE 200100572 A EE200100572 A EE 200100572A
Authority
EE
Estonia
Prior art keywords
thienylbenzyl
imidazole
pharmaceutical preparation
therapeutic use
preparation containing
Prior art date
Application number
EEP200100572A
Other languages
English (en)
Inventor
Heitsch Holger
Wiemer Gabriele
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1999120815 external-priority patent/DE19920815A1/de
Priority claimed from DE1999161686 external-priority patent/DE19961686A1/de
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200100572A publication Critical patent/EE200100572A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200100572A 1999-05-05 2000-04-29 1-(p-tienüülbensüül)imidasool, seda sisaldav farmatseutiline preparaat ja nende raviotstarbeline kasutamine EE200100572A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1999120815 DE19920815A1 (de) 1999-05-05 1999-05-05 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE1999161686 DE19961686A1 (de) 1999-12-21 1999-12-21 1-(p-Thienylbenzyl)-Imidazole als Agonisten von Angiotensin-1(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2000/003891 WO2000068226A1 (de) 1999-05-05 2000-04-29 1-(p-thienylbenzyl)-imidazole als agonisten von angiotensin-(1-7)-rezeptoren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate

Publications (1)

Publication Number Publication Date
EE200100572A true EE200100572A (et) 2003-02-17

Family

ID=26053245

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100572A EE200100572A (et) 1999-05-05 2000-04-29 1-(p-tienüülbensüül)imidasool, seda sisaldav farmatseutiline preparaat ja nende raviotstarbeline kasutamine

Country Status (25)

Country Link
US (3) US6235766B1 (et)
EP (1) EP1185527B1 (et)
JP (1) JP2002544130A (et)
KR (1) KR20020012207A (et)
CN (1) CN1158279C (et)
AR (1) AR023837A1 (et)
AT (1) ATE300535T1 (et)
AU (1) AU775244B2 (et)
BR (1) BR0010248A (et)
CA (1) CA2373010A1 (et)
CZ (1) CZ20013907A3 (et)
DE (1) DE50010835D1 (et)
EE (1) EE200100572A (et)
HK (1) HK1045519B (et)
HR (1) HRP20010814A2 (et)
HU (1) HUP0201311A3 (et)
IL (1) IL146198A0 (et)
NO (1) NO20015309L (et)
NZ (1) NZ515242A (et)
PL (1) PL351609A1 (et)
RU (1) RU2247121C2 (et)
SK (1) SK15942001A3 (et)
TR (1) TR200103171T2 (et)
WO (1) WO2000068226A1 (et)
YU (1) YU78601A (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
US6329159B1 (en) * 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
DE10112041A1 (de) 2001-03-14 2002-09-26 Aventis Pharma Gmbh p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
KR100938817B1 (ko) * 2001-05-31 2010-01-26 바이코어 파마 아베 안지오텐신 ⅱ 작용제로 유용한 삼중고리 화합물
US6610726B2 (en) * 2001-06-29 2003-08-26 North Shore-Long Island Jewish Research Institute Compositions and agents for modulating cellular proliferation and angiogenesis
CA2464561A1 (en) * 2001-10-25 2003-05-01 Depomed, Inc. Methods of treatment using a gastric retained losartan dosage
WO2003072059A2 (en) * 2002-02-27 2003-09-04 Wake Forest University Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
EP1348440A1 (en) * 2002-03-28 2003-10-01 Citeq B.V. Use of angiotensin 1-7 for enhancing cardiac function
NL1021048C2 (nl) 2002-07-11 2004-01-13 Weir Netherlands B V Zuigermembraanpomp.
WO2004046141A1 (en) * 2002-11-21 2004-06-03 Vicore Pharma Ab New tricyclic angiotensin ii agonists
WO2004046137A1 (en) * 2002-11-21 2004-06-03 Vicore Pharma Ab New tricyclic angiotensin ii agonists
WO2004085420A1 (en) * 2003-03-24 2004-10-07 Vicore Pharma Ab Bicyclic compounds useful as angiotensin ii agonists
EP1802361B1 (en) 2004-10-21 2009-11-18 Medtronic, Inc. Angiotensin-(1-7) eluting polymer-coated medical device to reduce restenosis and improve endothelial cell function
ES2395194T3 (es) * 2005-04-12 2013-02-11 Vicore Pharma Ab Nuevos agonistas tricíclicos de la angiotensina II
BRPI0502497A (pt) * 2005-06-28 2007-02-06 Univ Minas Gerais uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças
BRPI0602366B1 (pt) * 2006-04-26 2017-12-12 Universidade Federal De Minas Gerais Use of agonists of the receptor coupled to protein g, but, in the treatment of metabolic syndrome, its components and their complications
WO2008052179A2 (en) * 2006-10-27 2008-05-02 Medtronic, Inc. Angiotensin (1-7) eluting stent
KR100885197B1 (ko) * 2008-09-25 2009-02-24 박창수 다면다각형상 구현이 용이한 엘이디조명 램프용 인쇄회로기판
EP2163259B1 (en) 2008-09-12 2012-06-13 Charité-Universitätsmedizin Berlin (Charité) Use of an Ang-(1-7) receptor agonist in acute lung injury
AU2012351939A1 (en) * 2011-12-16 2014-07-10 Tarix Pharmaceuticals Ltd. Angiotensins for treatment of fibrosis
WO2013119870A1 (en) * 2012-02-10 2013-08-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of peripheral vascular disease
US8557958B1 (en) * 2012-06-18 2013-10-15 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of diabetes
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
US9943509B2 (en) 2013-03-15 2018-04-17 University Of Southern California Methods, compounds, and compositions for the treatment of musculoskeletal diseases
RU2015141336A (ru) * 2013-04-19 2017-05-22 Юниверсити Оф Айова Рисерч Фаундэйшн Ангиотензины при мышечной дистрофии
KR20160016872A (ko) 2013-05-24 2016-02-15 타릭스 파마슈티컬스 엘티디. 마르팡 증후군 및 관련 장애의 치료에서의 안지오텐신 펩티드
US9333233B2 (en) 2014-02-25 2016-05-10 Tarix Pharmaceuticals Ltd. Methods and compositions for the delayed treatment of stroke
WO2017066552A1 (en) 2015-10-14 2017-04-20 Tarix Pharmaceuticals Ltd. Methods and compositions for the treatment of epidermolysis bullosa
BR112018077075A2 (pt) 2016-06-29 2019-04-30 Universite De Montreal heterociclos de biarilmetila
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
GB201913603D0 (en) * 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
US20230110554A1 (en) 2020-03-13 2023-04-13 Constant Therapeutics Llc Methods and compositions for treatment of coronavirus infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5140037A (en) * 1990-03-20 1992-08-18 E. I. Du Pont De Nemours And Company Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists
CA2058198A1 (en) * 1991-01-04 1992-07-05 Adalbert Wagner Azole derivatives, process for their preparation, and their use
US5177074A (en) 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5252574A (en) 1991-04-26 1993-10-12 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted thiophene or furan
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5256667A (en) 1991-09-25 1993-10-26 Merck & Co., Inc. Quinazolinones and pyridopyrimidinones
WO1994027597A1 (en) * 1993-05-21 1994-12-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acid angiotensin ii receptor antagonists
US5444067A (en) 1993-08-30 1995-08-22 Merck & Co., Inc. Pharmaceutical treatment methods using angiotensin II receptor agonists bearing a thiophene moiety
FR2716882B1 (fr) * 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.

Also Published As

Publication number Publication date
EP1185527A1 (de) 2002-03-13
HK1045519A1 (en) 2002-11-29
JP2002544130A (ja) 2002-12-24
NO20015309L (no) 2001-12-28
CN1158279C (zh) 2004-07-21
ATE300535T1 (de) 2005-08-15
US20020077344A1 (en) 2002-06-20
CZ20013907A3 (cs) 2002-02-13
HK1045519B (zh) 2005-04-22
BR0010248A (pt) 2002-02-13
NZ515242A (en) 2003-11-28
AU775244B2 (en) 2004-07-22
TR200103171T2 (tr) 2002-06-21
YU78601A (sh) 2005-07-19
US20010018449A1 (en) 2001-08-30
CN1349530A (zh) 2002-05-15
HRP20010814A2 (en) 2003-02-28
WO2000068226A1 (de) 2000-11-16
KR20020012207A (ko) 2002-02-15
US6235766B1 (en) 2001-05-22
AR023837A1 (es) 2002-09-04
HUP0201311A3 (en) 2003-03-28
NO20015309D0 (no) 2001-10-30
US6429222B2 (en) 2002-08-06
DE50010835D1 (de) 2005-09-01
IL146198A0 (en) 2002-07-25
CA2373010A1 (en) 2000-11-16
PL351609A1 (en) 2003-05-05
HUP0201311A2 (en) 2002-10-28
SK15942001A3 (sk) 2002-04-04
RU2247121C2 (ru) 2005-02-27
EP1185527B1 (de) 2005-07-27
AU4753600A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
EE200100572A (et) 1-(p-tienüülbensüül)imidasool, seda sisaldav farmatseutiline preparaat ja nende raviotstarbeline kasutamine
DE60033176D1 (de) Medikamentspender
DE60016271D1 (de) Medikamentenzuführvorrichtung
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP0203403A3 (en) New imidazole derivatives, pharmaceutical compositions containing them and their use
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
HUP0201314A3 (en) Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof and pharmaceutical compositions containing them
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
DE60019949D1 (de) Arzneimittel enthaltendes system zur oralen abgabevorrichtung
DE50002776D1 (de) Fungizide wirkstoffkombinationen
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
EE200100391A (et) Peptidüül-heterotsüklilised ketoonid, nende kasutamine ja farmatseutiline kompositsioon
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE60010464D1 (de) Geschmackskaschierte flüssige arzneizubereitungen
NO985368L (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
EE200200041A (et) Karboksüülhappeamiidid, neid ühendeid sisaldavad ravimid, nende kasutamine ja valmistamine
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO20020531D0 (no) Beta-carbolin medikament produkter
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
EE200100662A (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
HUP0303155A3 (en) 2-thio-substituted imidazole derivatives, the use thereof and pharmaceutical compositions containing them
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid